COST-EFFECTIVENESS OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Vitale, A. [1 ]
Spolverato, G. [1 ]
Burra, P. [1 ]
De Feo, T. M. [2 ]
Cillo, U. [1 ]
Fagiuoli, S. [3 ]
机构：
[1] Univ Hosp Padua, Padua, Italy
[2] Fdn IRCCS Ca Granda OMP, North Italy Transplant Program, Milan, Italy
[3] Osped Papa Giovanni XXIII, Bergamo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2015年 / 47卷
关键词：
D O I：
10.1016/j.dld.2015.01.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-14
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION
    Vitale, A.
    Spolverato, G.
    Burra, P.
    Cillo, U.
    Fagiuoli, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S301 - S302
  • [2] The Cost-Effectiveness of Sofosbuvir Treatment Pre-Transplant to Prevent HCV Recurrence Post-Transplant
    Agarwal, Kosh
    Gane, Ed
    Forns, Xavier
    Manns, Michael
    Saab, Sammy
    Colombo, Massimo
    Younossi, Zobair
    Terrault, Norah
    McHutchison, John
    LIVER TRANSPLANTATION, 2014, 20 : S148 - S148
  • [3] POTENTIAL NET HEALTH BENEFIT OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION: A MULTICENTER, COHORT MODEL STUDY
    Vitale, A.
    Spolverato, G.
    Burra, P.
    De Feo, T. M.
    Belli, L.
    Donato, F.
    Baroni, G. Svegliati
    Marianelli, T.
    Picciotto, A.
    Toniutto, P.
    Bhoori, S.
    Passigato, N.
    Luca, M. G.
    Cillo, U.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E132 - E133
  • [4] POTENTIAL NET HEALTH BENEFIT OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION: A MULTICENTER, COHORT MODEL STUDY
    Vitale, A.
    Spolverato, G.
    Burra, P.
    Feo, T. M. D.
    Belli, L.
    Donato, F.
    Bitetto, D.
    Marinelli, T.
    Picciotto, A.
    Toniutto, P.
    Bhoori, S.
    Passigato, N.
    Cillo, U.
    Fagiuoli, S.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 11 - 12
  • [5] Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection after Liver Transplantation
    Curry, Michael P.
    Forns, Xavier
    Chung, Raymond T.
    Terrault, Norah
    Brown, Robert S.
    Fenkel, Jonathan M.
    Gordon, Fredric D.
    O'Leary, Jacqueline G.
    Kuo, Alexander
    Schiano, Thomas D.
    Everson, Gregory T.
    Schiff, Eugene R.
    Befeler, Alex
    McHutchison, John G.
    Symonds, William T.
    Denning, Jill M.
    McNair, Lindsay
    Arterburn, Sarah
    Moonka, Dilip
    Gane, Edward J.
    Afdhal, Nezam H.
    HEPATOLOGY, 2013, 58 : 314A - 315A
  • [6] Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
    Curry, Michael P.
    Forns, Xavier
    Chung, Raymond T.
    Terrault, Norah A.
    Brown, Robert, Jr.
    Fenkel, Jonathan M.
    Gordon, Fredric
    O'Leary, Jacqueline
    Kuo, Alexander
    Schiano, Thomas
    Everson, Gregory
    Schiff, Eugene
    Befeler, Alex
    Gane, Edward
    Saab, Sammy
    McHutchison, John G.
    Subramanian, G. Mani
    Symonds, William T.
    Denning, Jill
    McNair, Lindsay
    Arterburn, Sarah
    Svarovskaia, Evguenia
    Moonka, Dilip
    Afdhal, Nezam
    GASTROENTEROLOGY, 2015, 148 (01) : 100 - U519
  • [7] Pre-transplant sofosbuvir and ribavirin for patients with advanced liver disease and chronic hepatitis C awaiting deceased donor liver transplantation: A cost-effectiveness analysis
    Wright, Alissa J.
    Kim, Arthur Y.
    Fishman, Jay A.
    Linas, Benjamin P.
    Chung, Raymond T.
    HEPATOLOGY, 2014, 60 : 1045A - 1045A
  • [8] A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION
    Logge, Christoph
    Vettorazzi, Eik
    Fischer, Lutz
    Nashan, Bjoern
    Sterneck, Martina
    HEPATOLOGY, 2009, 50 (04) : 553A - 553A
  • [9] Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation
    Vitale, Alessandro
    Spolverato, Gaya
    Burra, Patrizia
    De Feo, Tullia Maria
    Belli, Luca
    Donato, Francesca
    Baroni, Gianluca Svegliati
    Marianelli, Tania
    Picciotto, Antonio
    Toniutto, Pierluigi
    Bhoori, Sherrie
    Passigato, Nicola
    Luca, Maria Grazia
    Russo, Francesco Paolo
    Cillo, Umberto
    Fagiuoli, Stefano
    TRANSPLANT INTERNATIONAL, 2015, 28 (09) : 1055 - 1065
  • [10] Sofosbuvir and ribavirinin in hcv-infected patients listed for liver transplantation: a cost-effectiveness analysis
    Cortesi, Paolo A.
    Mantovani, Lorenzo G.
    Ciaccio, Antonio
    Rota, Matteo
    Cesana, Giancarlo
    Strazzabosco, Mario
    Belli, Luca S.
    HEPATOLOGY, 2014, 60 : 534A - 534A
12345